Chlorogenic acid
Sponsors
Chinese Academy of Medical Sciences, Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd, University Hospital Tuebingen, University of Guadalajara, National Nutrition and Food Technology Institute
Conditions
Advanced CancerAdvanced Lung CancerBlood PressureGlioblastomaImpaired Glucose ToleranceType 2 Diabetes Nonalcoholic Fatty Liver
Phase 1
Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer
TerminatedNCT02136342
Start: 2014-05-31Updated: 2014-10-21
Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers
CompletedNCT02245204
Start: 2014-09-30End: 2016-10-31Updated: 2018-11-21
Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
CompletedNCT02728349
Start: 2016-04-12End: 2017-09-13Updated: 2018-11-01
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
NCT03751592
Start: 2018-07-17End: 2021-04-30Target: 144Updated: 2018-11-26
Phase 2
Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
CompletedNCT02621060
Start: 2015-09-30End: 2016-02-29Updated: 2019-08-02
The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 Diabetes
CompletedNCT02929901
Start: 2016-12-31End: 2019-03-31Updated: 2019-05-01